Pharmaceutical

Center Laboratory Inc.

continues to develop diverse oral medical solutions and has gained an excellent reputation in the industry. In the future, we will continue to increase our competitiveness and strive to become the most professional oral liquid pharmaceutical company, a leader in CNS field and an expert in special drug development and the biotech industry bank.

Our Cultural Prospective

Care

we are committed to the development of innovative medications, the improvement of a patients’ quality of life, to the improvement of the quality of medicine and to the continuous commitment to the discussion and betterment of government policy. We aim to interconnect the resources and development ability of industry, government, and academia to promote an excellent and healthy industry environment.

Integrity

we are value-oriented; with sincere, respectful, and reciprocal attitudes towards our customers, building long and sustainable partnerships via professional interactions and continuous learning.

Professionalism

we are focusing on the development of excellence in the industry and specialize in accessing the knowledge of target fields. With strong ambitions and excellent teamwork, we aim to become leaders in the field. Through the talent program, we are trained to commit to our professional heritage.

Innovation

In between reality and our ideal goal, we utilize rational thinking and creativity to maintain existing achievements and implement a pragmatic future, creating new milestones.

Research And Development

Center Laboratory Inc. specializing in manufacturing oral medication is dedicated to the development of diverse liquid drugs/products. Through advanced technology platform integration, professional prescription research and prescription design analysis, we invent 3 – 5 new products annually; thus, able to continue in strengthening our innovation and competitiveness.

 

We have successfully overcome the challenge of the bitter taste in oral medicine, at the same time, solving the difficulties of maintaining the stability and solubility of drugs in solution. In new drug development connecting special medication for infants and young children, we analyzed the causes in the drugs administration struggle and the difficulties in potency adjustment. We continue developing oral medication on respiratory tract, gastrointestinal tract, central nervous system, and cardiovascular system. In addition, we are also developing medications for common disease in children (such as asthma and allergy etc.) and rare diseases, we are courageously resolving the challenges in maintaining the solubility and stability of poor-soluble drug in liquid state, and continuously developing new formulation drugs that currently unmet prescriptions need.

Manufacturing And Marketing

We are continuously improving factory requirement which already meet the highest national standards of PIC/S specification. Through the perspective of customers, we constantly enhance the packaging and label. Consistent operating procedures and an excellent professional marketing team with extensive knowledge of products to provide exclusive services to customers, we have completed a market layout of hospitals and clinics nationally. Furthermore, the collaboration between logistics systems has improved the annual production which has since reached 24 million bottles of oral medication and 60% of market share in Taiwan.

Looking Into The Future

  • Striving For Perfection

    Center Laboratory Inc. is the largest oral liquid medication pharmaceutical company in Taiwan. In the short term, we are committed in the development of CNS liquid medication, a special drug portfolio, brand development, patient care and disease management and product licensing out.
  • Cross-Striate Cooperation

    Incorporating the investment of Center Laboratory Inc. in mainland China, Univision pharmaceutical Co., LTD; completing cross-striate CNS special drug portfolio, establishing communication of clinical regularity and trade distribution, and accelerating market authorization and development, thus, we are creating the overall effectiveness of drug products of Center Laboratory Inc. in both Taiwan and mainland China. We aim to become a cross-strait brand image of the best pharmaceutical in CNS field and the best partner in cross-striate marketing for global/foreign pharmaceutical companies. We are stablishing and promoting the adjusted personalized drug models by defining the most optimal dosage and strengthen drug product portfolio and brand image. In the future, we hope to establish leadership in CNS field and expand this successful experience across Asia.
  • Global Vision

    Center Laboratory Inc. intends to be the most professional oral liquid medication and the leader in CNS drugs in Asia. From this base to integrating various recourses of R&D, clinical, regulatory, production and marketing, thus strengthening development of personalized/region-specific drug products, leading Center Laboratory Inc. not only as the leader in oral liquid medication and CNS drugs, but also as the expert in differentiated/personalized drugs.